Skip to main content
SpringerLink
Log in

The Imperial Cancer Research Fund—Cancer research for the future

  • Commentary
  • Published:

From Nature Medicine

View current issue Submit your manuscript

Abstract

Paul Nurse, winner of the 1998 Albert Lasker Basic Medical Research Award for his work on the cell cycle, began working at the Imperial Cancer Research Fund (ICRF) as Head of the Cell Cycle Control laboratory in 1984. Twelve years later he was appointed Director General of the ICRF and now describes the origins, structure and goal of the UK's largest cancer charity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Figure 1
Figure 2
Figure 3

Author information

Authors and Affiliations

  1. Director General Imperial Cancer Research Fund, 44 Lincoln's Inn Fields, London, WC2A 3PX, UK

    Paul Nurse

Authors
  1. Paul Nurse
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nurse, P. The Imperial Cancer Research Fund—Cancer research for the future . Nat Med 4, 1224–1227 (1998). https://doi.org/10.1038/3202

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1038/3202

  • Springer Nature America, Inc.

Search

Navigation